Advances in Autoimmune Myasthenia Gravis |
Autore | Le Panse Rozen |
Pubbl/distr/stampa | Frontiers Media SA, 2020 |
Descrizione fisica | 1 electronic resource (205 p.) |
Soggetto topico |
Medicine
Immunology |
Soggetto non controllato |
autoantibodies
CD4 T cells thymus therapy miRNA |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557762303321 |
Le Panse Rozen
![]() |
||
Frontiers Media SA, 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Myasthenia Gravis and Related Disorders / / edited by Henry J. Kaminski, Linda L. Kusner |
Edizione | [3rd ed. 2018.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Humana, , 2018 |
Descrizione fisica | 1 online resource (357 pages) : illustrations |
Disciplina | 573.7528 |
Collana | Current Clinical Neurology |
Soggetto topico |
Neurology
Neurosciences Immunology Respiratory organs - Diseases Neuroscience Pneumology |
ISBN | 3-319-73585-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Chapter 1. Neuromuscular Junction Physiology and Pathophysiology -- Chapter 2. Acetylcholine Receptor Structure -- Chapter 3. Immunopathogenesis of Myasthenia Gravis -- Chapter 4. Animal Models of Myasthenia Gravis for Preclinical Evaluation -- Chapter 5. Epidemiology and Genetics of Myasthenia Gravis -- Chapter 6. Clinical Presentations of Myasthenia Gravis -- Chapter 7. Ocular Myasthenia -- Chapter 8. Thymoma-associated Myasthenia Gravis -- Chapter 9. Electrodiagnosis of Neuromuscular Junction Disorders -- Chapter 10. Autoantibody Testing in the Diagnosis and Management of Autoimmune Disorders of Neuromuscular Transmission and Related Diseases -- Chapter 11. Treatment of Myasthenia Gravis -- Chapter 12. Neurocritical Care of Myasthenic Crisis -- Chapter 13. Thymectomy for Non-thymomatous Myasthenia Gravis -- Chapter 14. Lambert-Eaton Syndrome -- Chapter 15 Acquired Neuromyotonia -- Chapter 16. Congenital Myasthenic Syndromes -- Chapter 17. Toxic Neuromuscular Transmission Disorders -- Chapter 18. Predictors of Psychological Health in Myasthenia Gravis -- Chapter 19. Myasthenia Gravis: Classification and Outcome Measurements -- Chapter 20. Emerging Therapeutics for Myasthenia Gravis -- Chapter 21. Clinical Trial Design for Myasthenia Gravis. |
Record Nr. | UNINA-9910300267603321 |
Cham : , : Springer International Publishing : , : Imprint : Humana, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|